Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 19545157)

1.

Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology.

Song Q, Liu G, Hu S, Zhang Y, Tao Y, Han Y, Zeng H, Huang W, Li F, Chen P, Zhu J, Hu C, Zhang S, Li Y, Zhu H, Wu L.

J Proteome Res. 2010 Jan;9(1):30-9. doi: 10.1021/pr900131e.

2.

Identification of new autoimmune hepatitis-specific autoantigens by using protein microarray technology.

Wu L, Song G.

Methods Mol Biol. 2012;909:227-39. doi: 10.1007/978-1-61779-959-4_15.

PMID:
22903719
3.

Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis.

Zingaretti C, Arigò M, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R, Bonnal RJ, Marcatili P, Marconi M, Zignego A, Muratori P, Invernizzi P, Colombatto P, Brunetto M, Bonino F, De Francesco R, Geginat J, Pagani M, Muratori L, Abrignani S, Bombaci M.

Mol Cell Proteomics. 2012 Dec;11(12):1885-97. doi: 10.1074/mcp.M112.018713. Epub 2012 Sep 20.

4.

Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Hu CJ, Song G, Huang W, Liu GZ, Deng CW, Zeng HP, Wang L, Zhang FC, Zhang X, Jeong JS, Blackshaw S, Jiang LZ, Zhu H, Wu L, Li YZ.

Mol Cell Proteomics. 2012 Sep;11(9):669-80. doi: 10.1074/mcp.M111.015529. Epub 2012 May 30.

6.

Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.

Csepregi A, Obermayer-Straub P, Kneip S, Kayser A, Loges S, Schmidt E, Nemesánszky E, Szalay F, Manns MP, Strassburg CP.

Clin Dev Immunol. 2003 Jun-Dec;10(2-4):173-81.

7.

Autoantibodies and autoantigens in autoimmune hepatitis.

Strassburg CP, Manns MP.

Semin Liver Dis. 2002 Nov;22(4):339-52. Review.

PMID:
12447706
8.

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.

Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Büschenfelde KH, Lohse AW.

Lancet. 2000 Apr 29;355(9214):1510-5.

PMID:
10801173
9.

[Cloning and expression of 3-phosphoglycerate dehydrogenase gene and its correlative antibodies in diagnosis of autoimmune hepatitis].

XIANG DJ, YAN HP, XIA Q, LU F, FENG X, ZHAO Y, LIU Y, YANG JX.

Zhonghua Gan Zang Bing Za Zhi. 2009 May;17(5):378-82. Chinese.

PMID:
19497206
10.

Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis.

Matsuo I, Ikuno N, Omagari K, Kinoshita H, Oka M, Yamaguchi H, Kohno S, Mackay IR.

J Gastroenterol. 2000;35(3):226-34.

PMID:
10755693
11.

Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis.

Xia Q, Lu F, Yan HP, Wang HX, Feng X, Zhao Y, Liu BY, Wang J, Li P, Xue Y, Hu MR, Qian L, Guo N, Yang SC, Li MY, Ma YF, Li BA, Zhang XM, Shen BF.

J Proteome Res. 2008 May;7(5):1963-70. doi: 10.1021/pr700861s. Epub 2008 Mar 21.

PMID:
18355017
13.

Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool.

Tahiri F, Le Naour F, Huguet S, Lai-Kuen R, Samuel D, Johanet C, Saubamea B, Tricottet V, Duclos-Vallee JC, Ballot E.

Hepatology. 2008 Mar;47(3):937-48. doi: 10.1002/hep.22149.

PMID:
18306218
14.

Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.

Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L.

Clin Dev Immunol. 2013;2013:572815. doi: 10.1155/2013/572815. Epub 2013 Jan 16.

15.

Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.

Orth T, Gerken G, Meyer Zum Büschenfelde KH, Mayet WJ.

Z Gastroenterol. 1997 Feb;35(2):113-21.

PMID:
9066101
16.

Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.

Strassburg CP, Alex B, Zindy F, Gerken G, Lüttig B, Meyer zum Büschenfelde KH, Bréchot C, Manns MP.

J Hepatol. 1996 Dec;25(6):859-66.

PMID:
9007714
17.

Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis.

Lu F, Xia Q, Ma Y, Yuan G, Yan H, Qian L, Hu M, Wang M, Lu H, Wang H, Liu B, Xue Y, Wang H, Li M, Shen B, Guo N.

Biochem Biophys Res Commun. 2008 Mar 7;367(2):284-90. Epub 2007 Dec 26.

PMID:
18154727
18.

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ.

Ann Rheum Dis. 2007 Apr;66(4):511-6. Epub 2006 Sep 19.

19.

Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.

Dalekos GN, Zachou K, Liaskos C, Gatselis N.

Eur J Intern Med. 2002 Aug;13(5):293-303.

PMID:
12144908
20.

Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.

Himoto T, Yoneyama H, Kurokohchi K, Inukai M, Masugata H, Goda F, Haba R, Watanabe S, Senda S, Masaki T.

Can J Gastroenterol. 2012 Mar;26(3):125-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk